Skip to main content

Animations

MJFF Publications

1871 - 1880 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Characterizing white matter alterations subject to clinical laterality in drug‐naïve de novo Parkinson's disease
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.25558
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2020.117568
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-021-02418-6
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.700714
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Contribution of rare variant associations to neurodegenerative disease presentation
    Journal Name: npj Genomic Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41525-021-00243-3
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Distinct progression patterns across Parkinson disease clinical subtypes
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51436
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0254597
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcab135
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.67604
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms22147292
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.